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Aims Previous studies have shown that prodromal angina (PA) occurs frequently in acute myocardial infarction (MI)
patients. However, the potential benefits of PA on ischaemic myocardial damage remain unknown.
Methods
and results
One-hundred and fifty-four patients with acute ST-segment elevation MI successfully treated with primary percutan-
eous coronary intervention (PPCI) were prospectively evaluated for new-onset PA in the week preceding infarction
and other factors known to influence myocardial salvage. Cardiovascular magnetic resonance was performed 8+3
days after MI for the assessment of area-at-risk (AAR), MI size, myocardial haemorrhage (MH), microvascular
obstruction (MO), and myocardial salvage index (MSI).
Patients with PA (n ¼ 60) compared with those without PA (n ¼ 94) showed similar AAR but significantly smaller
MI size leading to larger MSI (0.53+ 0.27 vs. 0.32+0.26, P, 0.001). Additionally, patients with PA had lower inci-
dence of MH (18 vs. 33%) and MO (22 vs. 46%) than non-PA patients (both P, 0.05). At univariate analysis, higher
MSI was associated with new-onset PA, lower myocardial oxygen consumption before PPCI, shorter time-to-PPCI,
and higher post-procedural TIMI flow-grade. Neither collateral circulation nor medications administered before PPCI
were associated to MSI. After correction for other covariates by multivariate analysis, new-onset PA remained sig-
nificantly associated with MSI (b-value: 0.352, P, 0.001).
Conclusion In acute MI patients, new-onset PA is associated with higher MSI independent of others factors known to influence
jeopardized myocardium, as well as with less microvascular damage.
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Introduction
The pathophysiological basis of ischaemic myocardial damage has
been deeply investigated thoroughly in animal models of reper-
fused and non-reperfused myocardial infarction (MI), yet remains
poorly understood in humans.1,2 This apparent paradox may be
explained considering that: (i) in the clinical scenario many vari-
ables, which are difficult to account for, may influence ischaemic
myocardial damage; (ii) the complexities inherent in the study of
jeopardized myocardium in humans. Experimentally, most of the
variation in infarct size is related to area-at-risk (AAR) and reper-
fusion status, and to a lesser extent to collaterals, haemodynamic
determinants of myocardial metabolic demand, and medications.1
Moreover, brief episodes of myocardial ischaemia before sustained
ischaemia reduces MI size, a phenomenon known as ischaemic pre-
conditioning (IPC).3 In humans, acute MI is often preceded by pro-
dromal angina (PA), and previous clinical studies suggested that PA
may limit MI size through various mechanisms, including collaterals
Copy Edited by: A.K.
Language used: UK/ize
* Corresponding author. Tel: +39 050 315 2824; Fax: +39 050 315 2166, Email: masci@ftgm.it
Published on behalf of the European Society of Cardiology. All rights reserved. & The Author 2013. For permissions please email: journals.permissions@oup.com
European Heart Journal – Cardiovascular Imaging
doi:10.1093/ehjci/jet063
NOT FOR PUBLIC RELEASE
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
105
110
recruitment,4 reperfusion facilitation,5 and IPC.6– 11 However,
these studies were conducted in highly selected populations and
limited by the retrospective nature. Therefore, whether PA
confers cardioprotection in patients with acute MI is still a
matter of debate.
Cardiovascular magnetic resonance (CMR) is a valuable tool to
investigate this issue because it allows an accurate and comprehen-
sive assessment of ischaemic myocardial damage in the early post-
infarction period.12,13 Based on these premises, we prospectively
studied a cohort of acute MI patients with the aim of examining
the influence of PA on myocardial salvage using CMR.
Methods
Study population
Between January 2011 and January 2012, 212 consecutive acute
ST-segment elevation MI patients [95 at Fondazione ‘G. Monasterio’-
Italy, Pisa & Massa (Centre A), 63 at La Sapienza University, Rome,
Italy (Centre B) and 54 at Centro Cardiologico Monzino, Milan, Italy
(Centre C)] were prospectively evaluated for study enrolment. CMR
was performed 8+3 days after MI. Inclusion criteria were: (i) chest
pain suggestive of myocardial ischaemia lasting .30 min; (ii) ECG
showing ST-segment elevation .0.1 mV in ≥2 limb leads or
.0.2 mV in ≥2 contiguous precordial leads, or presumed new left
bundle-branch block; (iii) successful treatment with primary percutan-
eous coronary intervention (PPCI) within 12 h from symptoms onset;
(iv) ability to provide detailed clinical history. Exclusion criteria were
prior MI or revascularization, atrial fibrillation, Killip class .II, renal
failure [creatinine .2 mg/dL (0.226 mmol/dL)] and contraindications
to CMR. The study complied with the Declaration of Helsinki, the
Ethics Committee approved the research protocol, and informed
consent was obtained from each subject.
Clinical variables
Within 5 days from admission, clinical history was recorded from each
patient by one of the physicians participating to the study. Particular
attention was paid to assess new-onset PA, defined as one or more
episode of typical chest pain lasting ≤30 min at rest or on effort
within 7 days from the infarction.5,6 The number of PA episodes and
the time intervals between the first and last episode of PA and infarc-
tion were registered. Time-to-PPCI was defined as the interval time
between the onset of continuous chest pain and the re-opening of
the infarct-related artery by PPCI.
Blood pressure and heart rate values before PPCI were collected
from clinical documents completed in the ambulance, emergency de-
partment, intensive coronary care unit, and catheterization laboratory.
Mean rate pressure product (mRPP), which correlates with myocardial
oxygen consumption before PPCI,14 was calculated by multiplying
mean systolic blood pressure and mean heart rate. The use of nitrates,
morphine, beta-blockers, and Gp IIb/IIIa before PPCI were also
recorded.
Coronary angiography analysis
All coronary angiograms were analysed at Centre A by an experienced
physician blinded to clinical and CMR data. The TIMI flow-grade of the
infarcted-related artery was assessed before and after PPCI. The grade
of epicardial collaterals to the infarcted-related artery was evaluated
according to Rentrop et al.15; collateral circulation was defined as
Rentrop grade ≥2. Double- and triple-vessel coronary disease were
diagnosed when a ≥75% stenosis in one or two vessels remote
from the infarct-related artery, respectively. All patients received
dual anti-platelet therapy upon admission.
CMR protocol
CMR studies were performed at Centre A with 1.5-T unit (CVi,
GE-Healthcare, Milwaukee, USA), at Centre B with 1.5-T unit
(Avanto Siemens, Erlangen, Germany), and at Centre C with 1.5-T
unit (Discovery MR450, GE-Healthcare, Milwaukee, USA). All studies
were performed using dedicated cardiac software, phased-array
surface receiver coil, and electrocardiogram triggering. A similar
CMR study protocol was followed in all centres (see Supplementary
material online). Breath-hold steady-state free-precession cine CMR
was performed in vertical and horizontal long-axis, and in short-axis
orientations. In short-axis, both ventricles were completely encom-
passed by a stack of contiguous slices. Breath-hold black-blood
T2-weighted short inversion-time inversion-recovery fast spin-echo
(T2w-imaging) was performed in short-axis orientation for AAR quan-
tification. Breath-hold contrast-enhanced segmented T1-weighted
inversion-recovery gradient-echo sequence [late-gadolinium enhance-
ment (LGE)-imaging] was used to quantify MI and microvascular ob-
struction (MO). 10–20 min after an intravenous bolus of 0.1 mmol/
kg Gadolinium-BOPTA (Multihance-Bracco, Milan, Italy) or 0.2 mmol/
kg Gadolinium-BOPTA Gadolinium-DOTA (Dotarem Guerbet
Roissy, France) LGE-imaging was performed. Inversion time was indi-
vidually adapted to nullify the signal of remote myocardium (usual
range 220–300 ms).
Image analysis
All CMR studies were analysed off-line by the consensus of two
experienced observers at Centre A using a workstation (Advantage
Workstation, GE-Healthcare, Milwaukee, USA) with a dedicated soft-
ware (MASS 6.1, Medis, Leiden, the Netherlands). Operators were
unaware of clinical and angiographic data. Analysis was started by
scoring T2w-imaging quality using a 4-grade score: (1) poor, (2) mod-
erate, (3) good, and (4) excellent. Only exams with a score .2 were
included. T2w-imaging was used to quantify AAR and visualize myocar-
dial haemorrhage (MH). Myocardium with a signal intensity (SI) .2 SD
above mean SI of remote non-infarcted myocardium was considered
AAR. Attention was paid to exclude increased SI from the blood adja-
cent to endocardium (‘slow flow’). MH was defined as a hypo-intense
area in the core of AAR. When present, MH was included in hyper-
intense myocardium for AAR calculation.12 On post-contrast imaging,
LGE was considered present if SI of the hyperenhanced myocardium
was .5 SD above the mean SI of remote myocardium,16 whereas
MO was defined as hypo-enhanced region within the infarcted myocar-
dium. When present, MO was included in the hyper-intense myocar-
dium for LGE quantification. Left-ventricular (LV) LGE and MO were
expressed as absolute (grams) or relative (LV percentage) value.
Infarct transmurality was calculated as the ratio of mean thickness of
hyperenhanced myocardium to mean thickness of the corresponding
myocardial wall, multiplied by 100. Cine CMR was used to derive LV
volumes, ejection-fraction, regional wall motion, and mass. For LV
wall motion analysis, we used the 17-segment model proposed by
AHA17 (segment 17 was excluded from analysis). Regional wall
motion was scored for each segment from 1 to 5 (1: normal/mild hypo-
kinesia; 2: moderate hypokinesia; 3: severe hypokinesia; 4: akinesia; 5:
dyskinesia). Wall motion score index (WMSI) was determined as the
sum of segmental scores divided by the number of segments.13
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Statistical analysis
Continuous variables were expressed as mean+ SD or median
(25th–75th percentiles). Kolmogorov–Smirnov test was used to
assess the normality of data distribution, and variables distributed non-
normally were logarithmically transformed. Categorical variables were
expressed as frequency with percentage. Student’s independent t- or
Mann–Whitney tests were used, as appropriate, to compare continu-
ous variable differences. Comparisons between categorical variables
were made with x2 test or Fisher’s exact test, if an expected cell
count was ,5. Correlations between continuous variables were
assessed using Pearson’s (r) coefficient or Spearman’s rho, as appropri-
ate. Univariate linear regression analysis was utilized to determine the
association of variables with MSI. Variables known to influence MSI
were tested as potential covariates.1–10 Multivariate linear regression
analysis was used to evaluate the influence of covariates on MSI. Vari-
ables with a P-value ,0.10 at univariate analysis were entered in the
multivariable model as covariates. Statistical analysis was performed
by SPSS software for Windows (15.0 release; SPSS, Chicago, IL,
USA); all tests were two-tailed at 5% significance level.
Results
Study population
Thirty-five (18%) patients were excluded from the study because
of inadequate T2w-imaging quality, thus leaving a total of 154
patients for the analysis (124 men, age 62+ 11 years; Figure 1Q2 ).
Patients were dichotomized according to the presence (n ¼ 60)
or absence (n ¼ 94) of new-onset PA. Baseline characteristics
are summarized in Table 1. Peak troponin I was lower in patients
with than those without PA. Notably, mRPP before PPCI, TIMI
flow-grade before and after PPCI and Rentrop-grade were
similar in the two groups. Nitrate use before PPCI was more
common in patients with PA.
Prodromal angina characteristics
The characteristics of PA are summarized in Table 2. Twenty-eight
patients (47%) referred only one episode of PA, whereas the
remaining 32 patients (53%) had repeated episodes in the week
preceding infarction. Notably, 58 (97%) and 31 (52%) patients
experienced the last episode of PA within 48 and 6 h from infarc-
tion, respectively. The two patients presenting PA. 48 h had one
single episode of angina occurring 55 and 72 h before infarction.
Prodromal angina and ischaemic
myocardial damage
CMR findings are summarized in Table 3. Patients with and without
PA showed similar AAR although LGE extent was significantly
lower in patients with PA, resulting in higher MSI. Infarct transmur-
ality was also lower in patients with PA compared with those
without PA (Figure 2). As a result, patients with PA had better re-
gional and global LV systolic function than patients without PA. In
addition, aborted MI (evidence of AAR on T2w-imaging but the
absence of LGE on LGE-imaging) was more commonly observed
in patients with than those without PA [8(13%) vs. 3(3%),
P ¼ 0.017]. Patients with PA also showed lower incidence of MH
Figure 1 Study protocol.
Prodromal angina is associated with myocardial salvage
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and MO. When including only patients with pre-PPCI TIMI flow-
grade ≤1 and Rentrop-grade ≤1 (n ¼ 128), MSI remained higher
and infarct transmurality was lower in patients with PA than
those without PA (0.49+ 0.26 vs. 0.34+0.26, P ¼ 0.003 and
57+32 vs. 72+ 30%, P ¼ 0.029; respectively).
The influence of PA on jeopardized
myocardium
In the overall population, MSI was 0.40+0.28 and had a normal
distribution (Kolmogorov–Smirnov: 1.041, P ¼ 0.229). There was
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Baseline patients characteristics
Characteristics Presence of PA (n5 60) Absence of PA (n 5 94) P-value
Age (years) 60+12 63+10 0.146
Male, n (%) 49 (82) 75 (80) 0.774
Cardiovascular risk factors, n (%)
Hypertension 30 (50) 54 (58) 0.328
Diabetes 9 (15) 17 (18) 0.598
Hypercholesteraemia 23 (38) 42 (45) 0.404
Family history CAD 22 (37) 39 (42) 0.516
Current smokers 32 (53) 43 (46) 0.391
Killip class II 2 (3) 7 (7) 0.299
Peak troponin I (ng/dL) 31 [10–77] 71 [22–115] 0.002
Time-to-PPCI (min) 245+162 248+166 0.908
Haemodynamic parameters before PPCI
Mean systolic BP (mmHg) 138+19 135+17 0.232
Mean diastolic BP (mmHg) 82+11 78+10 0.004
Mean heart rate (bpm) 76+13 75+16 0.692
Mean RPP ([bpm] mmHg) 10 430+2419 10 136+2846 0.514
Medications before PPCI, n (%)
Beta-blocker 7 (12) 9 (10) 0.659
Nitrate 29 (51) 30 (33) 0.030
Morphine 13 (22) 22 (24) 0.833
Gp IIb/IIIa 7 (11) 18 (19) 0.152
Catheterization laboratory data
Infarct-related artery, n (%) 0.497
LAD 33 (55) 44 (46)
LCx 8 (13) 12 (13)
RCA 19 (32) 38 (41)
Double-vessel disease, n (%) 20 (33) 28 (30) 0.643
Triple-vessel disease, n (%) 7 (12) 7 (7) 0.324
Use of Gp IIb/IIIa, n (%) 26 (44) 42 (45) 0.968
Thrombus aspiration n (%) 30 (50) 51 (54) 0.606
TIMI flow-grade pre-PPCI, n (%) 0.647
0/1 55 (92) 88 (94)
2/3 5 (8) 6 (5)
TIMI flow-grade post-PPCI, n (%) 0.320
0/1 2 (3) 1 (1)
2/3 58 (97) 93 (99)
Presence of collaterals, n (%) 5 (8) 12 (13) 0.392
Rentrop grade 0.23+0.70 0.32+0.78 0.489
Medications at discharge, n (%)
ACE-i/ARBs 48 (84) 80 (87) 0.640
Beta-blocker 49 (86) 74 (80) 0.387
Statins 54 (95) 89 (97) 0.646
Spironolactone 10 (17) 21 (22) 0.440
ACE, angiotensin-converting enzyme; ARBs, angiotensin receptor blocker; BP, blood pressure; CAD, coronary artery disease; LAD, left-anterior descending coronary artery; LCx,
left circumflex coronary artery; PA, prodromal angina; PPCI, primary percutaneous coronary intervention; RCA, right coronary artery; RPP, rate pressure product; TIMI,
thrombolysis in myocardial infarction.
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a weak inverse relationship between MSI and time-to-PPCI (r ¼
20.173, P ¼ 0.031). Dichotomizing patients on the basis of PA, MSI
remained inversely related to time-to-PPCI in patients without PA
(r ¼ 20.291, P ¼ 0.004) but not in those with PA (r ¼ 20.025,
P ¼ 0.850). Similarly, in the overall population, MSI was inversely
related to pre-PCCI mRPP (r ¼ 20.191, P ¼ 0.019), but when
patients were dichotomized on the basis of PA, MSI remained inver-
sely related to pre-PPCI mRPP in patients without PA (r ¼ 20.295,
P ¼ 0.004) but not in those with PA (r ¼ 20.103, P ¼ 0.422)
(Figure 3). Notably, in patients with PA, there was a positive
relationship between MSI and the number of PA episodes (Spear-
man’s rho¼ 0.332, P ¼ 0.010). On the other hand, no relationship
was observed between MSI and the time elapsed from the first
or last episode of PA to infarction (r ¼ 0.008, P ¼ 0.949 and
r ¼ 20.133, P ¼ 0.316, respectively). At univariate linear regression
analysis, shorter time-to-PPCI, lower pre-PPCI mRPP, higher post-
PPCI TIMI flow-grade, and the occurrence of PA were significantly
associated with larger MSI (Table 4). At multivariate linear regression
analysis, the occurrence of PA remained significantly associated with
MSI after correction for pre- and post-PPCI TIMI flow-grade,
pre-PPCI mRPP, and time-to-PPCI (Table 5).
Discussion
We showed that patients with acute MI experiencing new-onset
PA in the week preceding the infarction had higher MSI, less
infarct transmurality, and lower incidence of MH and MO than
patients without PA, resulting in better regional and global LV sys-
tolic function. Noteworthy, the occurrence of PA remained signifi-
cantly associated to higher MSI even after correction for other
factors implicated in ischaemic injury, including pre- and post-
procedural TIMI flow-grade, myocardial oxygen consumption
before PPCI, and time to revascularization. Moreover, in patients
with PA, the degree of MSI was positively related to the number
of episodes of PA.
Our study is novel in so far as we assessed the impact of new-
onset PA on myocardial salvage using CMR in the early post-
infarction period after accounting for factors known to influence
the ischaemic damage and which could be readily assessed. In com-
parison to patients without PA, those with new-onset PA showed
greater MSI, as a result of smaller MI size, less infarct transmurality,
and lower incidence of MH and MO. Previous studies have
reported that coronary occlusion in the early period of infarction
is highly dynamic,18 and Andreotti et al.5 have shown that in acute
MI patients treated with thrombolysis, the occurrence of PA
results in more rapid reperfusion, thus leading to smaller infarct
size. However, in our study, the residual blood flow to the myocar-
dium at risk through the infarct-related artery or epicardial collat-
erals was similar in patients with and without PA. Additionally,
when the analysis was limited to patients with pre-procedural TIMI
flow-grade ≤1 and Rentrop-grade ≤1, the degree of MSI remained
higher and infarct transmurality was lower in patients with PA. These
data indicate that IPC is likely a mechanism by which new-onset PA
protects the myocardium at risk.3
Experimentally, the cardioprotective effect of IPC has been con-
firmed by a plethora of data derived from diverse animal species. In
particular, it has been demonstrated that repetitive brief episodes
of ischaemia protect the myocardium from the subsequent sus-
tained ischaemia, limiting final MI size.3,19 Our findings expand pre-
vious observations made in humans that indentified IPC as the
putative mechanism underlying the beneficial effects of new-onset
PA on post-infarction LV function recovery,4,6,7,9,10 as well as on
short- and long-term prognosis.8,20,21 However, prior studies
were limited by the lack of direct measure of salvaged myocardium
and by their retrospective nature which did not allow to adjust for
factors potentially influencing myocardial salvage. In our study, we
prospectively analysed the variables known from previous experi-
mental and clinical studies to intervene on ischaemic damage.
Noteworthy, multivariate analysis confirmed that new-onset PA
in the week preceding MI was independently associated with a
higher MSI. Recently, in a subgroup analysis of a randomized con-
trolled trial demonstrating the cardioprotective effect of exenatide
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Characteristics of prodromal angina
Characteristics Range Median
[25th–75th]
Number of episodes of PA 1–9 2 [1–3]
Duration of first PA episode (min) 2–30 15 [6–20]
Time from PA first to acute MI (h) 0.2–167 10 [4–34]
Duration of last PA last (min) 3–30 20 [10–25]
Time from PA last to acute MI (h) 0.2–72 6 [1–22]
PA, prodromal angina; MI, myocardial infarction.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Cardiovascular magnetic resonance
characteristics
Variables Presence of
PA (n5 60)
Absence of
PA (n 5 94)
P-value
Area-at-risk (g) 29+17 30+18 0.832
LGE extent (g) 10 [3–24] 18 [9–30] 0.009
LGE extent (% LV) 8 [3–19] 14 [8–23] 0.007
MSI 0.53+0.27 0.32+0.26 ,0.001
MI transmurality (%) 53+33 74+29 0.001
MH, n (%) 11 (18) 31 (33) 0.047
MO, n (%) 13 (22) 40 (43) 0.008
MO extent (g) 5 [4–7] 4 [2–8] 0.437
LV-EDV (mL) 141+36 145+36 0.515
LV-ESV (mL) 64+29 71+26 0.136
LV-SV (mL) 77+19 74+21 0.463
CI (mL/m2) 2.69+0.69 2.71+0.74 0.848
LV-EF (%) 56+10 52+10 0.029
LV-mass (g) 135+30 132+37 0.529
LV-WMSI 1.502+0.334 1.660+0.405 0.030
CI, cardiac index; EDV, end-diastolic volume; EF, ejection fraction; ESV,
end-systolic volume; LV, left ventricular; MI, myocardial infarction; MO,
microvascular obstruction; MSI, myocardial salvage index; WMSI, wall motion
score index.
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Figure 2 T2w-imaging (A and C) and LGE-imaging (B and D) in two patients with acute infero/lateral MI. One patient referred two episodes of
PA within 48 h from infarction (upper panel), whereas the second patient was asymptomatic in the week preceding MI (bottom panel). Both
patients presented the same angiographic characteristics (pre-/post-PPCI: 0/3; Rentrop-grade: 0) and similar time-to-PPCI (233 vs. 247 min) and
mRPP before PPCI (10 143 vs. 10 127 [bpm] mmHg), nevertheless the patient with PA had higher MSI (0.68 vs. 0.05) and lower infarct trans-
murality (34 vs. 98%) when compared with patient without PA. Additionally, MH (C, arrow) and MO (D, arrow) were detected only in the
patient without PA.
Figure 3 Scatter plots and regression lines of MSI and logarithm (Log) of time-to-PPCI (A) and mRPP before PPCI (B) in the whole study
population (black regression line) and in patients with (red triangles, red regression line) and without PA (blue circle, blue regression line).
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in acute MI patients, Lonborg et al.11 showed that PA in the
3 months preceding MI was associated with higher MSI as quanti-
fied by CMR. However, this study had several limitations making
the interpretation of the results difficult. First, it cannot be
excluded that exenatide influenced the sub-study results; secondly,
no data on MH and MO were reported; thirdly, the time interval
between PA and infarction was not mentioned.
Experimentally, the cardioprotective effect of IPC is lost if the
interval between the preconditioning stimulus and infarction
exceeded few hours (classical IPC) to then reappear between 24
and 72 h after the initial IPC stimulus (delayed or ‘second
window’ of IPC).3,19 In humans, classic IPC has been reported
during percutaneous coronary angioplasty22 and cardiac
surgery,23 and the occurrence of new-onset PA within 24 h
from acute MI has been associated with smaller MI size and
better post-infarction LV function recovery9 and prognosis.20
Other groups have reported that PA within 48 h from acute MI
is also associated with enhanced recovery of LV function after in-
farction4,8 and better in-hospital prognosis.7 In our study, all except
two patients and more than half of patients experienced the last
episode of PA within 48 and 6 h from infarction, respectively, indi-
cating that classical or delayed IPC may account for the cardiopro-
tective effect of PA. However, MSI was not related to the time
elapsed from the first or last PA episode to acute MI. The inde-
pendence of the time interval between episodes of PA and the
degree of salvaged myocardium may be explained by the fact
that silent ischaemia also contributes to IPC. Although one may
argue that silent ischaemia might also occur in patients without
PA, it has been reported that patients with PA had higher preva-
lence of silent pre-infarction ischaemia on 24 h Holter monitoring
compared with asymptomatic patients.24 Furthermore, we also
found that in patients with PA, the degree of MSI was positively
related to the number of new-onset PA episodes. Whether this
finding indicates a cumulative cardioprotective effect of IPC in
humans cannot be clarified by our results and merits further inves-
tigation. Reasonably, our findings indicate that patients with at least
one episode of PA are more likely to be effectively preconditioned
than asymptomatic patients, and the likelihood of cardioprotection
is positively linked to the increasing number of PA episodes.
Interestingly, we also found that patients with PA had a lower
incidence of MH and MO than patients without PA, indicating a
more favourable pattern of post-infarction damage. Myocardial
haemorrhage invariably denotes a severe damage of coronary
microvasculature with leakage of red blood cells from injured
vessels, and it occurs only in reperfused MI thereby representing
a marker of post-reperfusion damage.12,25,26 One may speculate
that IPC mitigates post-reperfusion damage in humans with a par-
ticular beneficial effect on the coronary microvasculature. This
finding is consistent with experimental studies showing that IPC
minimizes post-reperfusion injury19 not only acting directly on car-
diomyocytes but also by preserving coronary microvasculature
function.27 Notably, in humans Komamura et al.28 demonstrated
that in patients with acute anterior MI, the occurrence of new-
onset PA is associated with higher post-reperfusion great cardiac
vein flow, reflecting better coronary microvascular function and
smaller infarct size compared with patients without PA. Similarly,
in acute MI patients undergoing PPCI, Takahashi et al.29 reported
that no-reflow phenomenon was less commonly observed in
patients with PA compared with those without PA.
According to our study results, the assessment of new-onset PA
in the week before infarction is of importance in studies testing
novel or adjunctive reperfusion strategies aiming to protect the
myocardium at risk, since the unbalanced distribution of this vari-
able between the intervention and control groups may alter the
final results.
Limitations
This was a three-centre study using different vendor CMR units,
even though a similar study protocol was used with centralized
data analysis. The determination of AAR by T2-weighted has limita-
tions due to the inherently low signal-to-noise ratio and the sus-
ceptibility of signal loss in cardiac structures distant from the
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 4 Univariate linear regression analysis for MSI
determinants
Baseline characteristics b-value P-value
Age 0.010 0.901
Female gender 0.072 0.376
Hypertension 0.018 0.825
Diabetes 0.060 0.458
Hypercholesterolaemia 0.024 0.769
Family history of CAD 20.050 0.543
Current smoking 0.014 0.861
Killip class 20.029 0.726
Time-to-PPCI 20.191 0.018
Prodromal angina 0.367 ,0.001
Infarct-related artery 20.012 0.883
TIMI flow-grade pre-PPCI 0.146 0.066
Presence of collaterals 20.028 0.732
TIMI flow-grade post-PPCI 0.185 0.022
mRPP before PPCI 20.191 0.019
Beta-blocker before PPCI 0.020 0.808
Nitrate before PPCI 20.100 0.227
Morphine before PPCI 20.017 0.841
Gp IIb/IIIA before PPCI 0.083 0.312
Abbreviations as reported in previous tables.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 5 Multivariate linear regression analysis for MSI
determinants
Baseline characteristics b-value P-value
Time-to-PPCI 20.172 0.018
Prodromal angina 0.352 ,0.001
TIMI flow-grade pre-PPCI 0.114 0.121
TIMI flow-grade post-PPCI 0.180 0.013
mRPP before PPCI 20.217 0.003
Abbreviations as reported in previous tables.
Prodromal angina is associated with myocardial salvage
Q3
Page 7 of 8
NOT FOR PUBLIC RELEASE
685
690
695
700
705
710
715
720
725
730
735
740
745
750
755
760
765
770
775
780
785
790
795
surface coil. However, all CMR units used an SI correction algo-
rithm to homogenize signal, and only patients with CMR exams
showing a good or excellent T2-weighted images were included
in the study. The parameters of T2-STIR sequence were slightly dif-
ferent across the diverse centres potentially resulting in discrepan-
cies in the quantification of the AAR. We did not provide clinical
nor CMR follow-up data. However, the study intended to investi-
gate the pathophysiological factors influencing ischaemic damage in
patients with acute MI. It is very likely that the beneficial effects of
PA in the early post-infarction period will translate into better LV
remodelling at mid- and long-term follow-up. Finally, the assess-
ment of PA relied on the quality of history taking in acutely hospi-
talized patients.
Conclusion
New-onset PA in the week preceding acute MI is associated with
larger myocardial salvage independent of other factors known to
influence the jeopardized myocardium. The PA beneficial effect
on salvaged myocardium is also associated with less coronary
microvasculature damage.
Supplementary material
Supplementary material is available at European Heart Journal –
Cardiovascular Imaging online.
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